Replies to post #414147 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

That is a hopeful schedule. Fairly fast despite the EMA/EU, which is horrible in terms of timing and bureaucracy.

[ccie1024]

Amgen’s timeline for Sotorasib...

An *approval before *publication...

[antihama]

Good stuff. And I would add the BTD PR to your list since it portends good news to come:

Dec. 8, 2020- Amgen's Sotorasib Granted Breakthrough Therapy Designation For Advanced Or Metastatic Non-Small Cell Lung Cancer Patients With KRAS G12C Mutation
Sotorasib Also Accepted Into FDA's Real-Time Oncology Review Pilot Program
New Drug Application Submission to FDA Planned by End of the Year
https://www.amgen.com/newsroom/press-releases/2020/12/amgens-sotorasib-granted-breakthrough-therapy-designation-for-advanced-or-metastatic-nonsmall-cell-lung-cancer-patients-with-kras-g12c-mutation

So the order of things is
1) TLD (then)
2) BTD
3,4,5,6, etc) Everything else